If you or someone you know has been impacted by cancer, you understand the desperate need for new, effective treatments. Revolution Medicines is making headlines for tackling some of cancer's toughest targets, offering a fresh wave of hope where little existed before.
Revolution Medicines is trending because they're achieving significant clinical progress against previously 'undruggable' cancer targets.
The company recently announced positive clinical data for their drug RMC-6236, which targets the challenging RAS pathway.